Skip to main content
Caplight Logo









cureVision

cureVision

Private
MunichHealthcare & Life Scienceshttps://curevision.de/

Last Round

Seed

Oct 7, 2025

Est. Valuation

$12.64M

Total Funding Raised

$4.09M

Company Overview

cureVision is a medical technology company that provides an AI-powered, all-in-one solution for the digital analysis, documentation, and management of chronic wounds.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Medical Imaging, Computer Vision

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

wound care AIdigital wound managementautomated wound assessment3D wound analysischronic wound managementmedical deviceMDR certifiedmedical computer vision3D wound imagingwound documentation softwarecontactless wound measurementEHR integrationHIS integrationhandheld medical devicemedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

cureVision Comparables

Compare cureVision with similar companies based on industry and business-model similarity.

cureVision comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
KroniKare
88%
eKare Inc.
86%
Pixacare
80%

cureVision Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 7, 2025
AcceleratorMar 28, 2024
GrantMar 23, 2023
SeedOct 18, 2022

cureVision Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 22, 2026

    Grew 17% QoQ, from 23 to 27 employees.

  • Jan 1, 2026

    Monthly visitors increased 65% MoM, reaching 1.2K.

cureVision Filings

Explore SEC and related filing metadata, where available.

cureVision filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about cureVision's valuation, stock price, and market status.

Is cureVision a public or private company?

cureVision is a private company.

What is the current stock price of cureVision?

cureVision is a private company, so its shares have no public market price. Caplight tracks cureVision's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is cureVision worth (valuation)?

cureVision's valuation is estimated at $12.6M based on funding round data.

Can I buy cureVision stock?

cureVision shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was cureVision's last funding round?

cureVision's most recent funding round was Seed on October 7, 2025.

Who are the main investors in cureVision?

Key investors in cureVision include Luminate Accelerator.

Will cureVision IPO soon?

No public IPO plans have been announced for cureVision.

How can I track cureVision secondary market activity?

Caplight tracks bids, offers, and trades in cureVision's shares on secondary markets.

Firmographic Details

HeadquartersMunich
Employee Range25
Year Founded2021
Last FundingOct 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?